Letter to the Editor
Efgartigimod for the treatment of Guillain–Barré syndrome with concurrent posterior reversible encephalopathy syndrome
Efgartigimod para el tratamiento del síndrome de Guillain-Barré con síndrome de encefalopatía posterior reversible concurrente
a Department of Neurology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang Province, China
b Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
c Department of Neurology, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province, China
